Cargando…
Metformin selectively dampens the acute inflammatory response through an AMPK-dependent mechanism
Metformin is a first-line drug in the treatment of type-2 diabetes mellitus (T2DM). In addition to its antigluconeogenic and insulin-sensitizing properties, metformin has emerged as a potent inhibitor of the chronic inflammatory response of macrophages. In particular, metformin treatment has been sh...
Autores principales: | Postler, Thomas S., Peng, Vincent, Bhatt, Dev M., Ghosh, Sankar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455559/ https://www.ncbi.nlm.nih.gov/pubmed/34548527 http://dx.doi.org/10.1038/s41598-021-97441-x |
Ejemplares similares
-
Metformin regulates myoblast differentiation through an AMPK-dependent mechanism
por: Maniscalco, Eleonora, et al.
Publicado: (2023) -
Metformin suppresses adipogenesis through both AMP-activated protein kinase (AMPK)-dependent and AMPK-independent mechanisms
por: Chen, Suet Ching, et al.
Publicado: (2017) -
Regulation of the NF-κB-Mediated Transcription of Inflammatory Genes
por: Bhatt, Dev, et al.
Publicado: (2014) -
Protective effects of metformin in various cardiovascular diseases: Clinical evidence and AMPK‐dependent mechanisms
por: Bu, Yizhi, et al.
Publicado: (2022) -
Metformin Induces Apoptosis through AMPK-Dependent Inhibition of UPR Signaling in ALL Lymphoblasts
por: Leclerc, Gilles M., et al.
Publicado: (2013)